232 related articles for article (PubMed ID: 28288570)
1. Effect of tolvaptan on renal water and sodium excretion and blood pressure during nitric oxide inhibition: a dose-response study in healthy subjects.
Al Therwani S; Rosenbæk JB; Mose FH; Bech JN; Pedersen EB
BMC Nephrol; 2017 Mar; 18(1):86. PubMed ID: 28288570
[TBL] [Abstract][Full Text] [Related]
2. Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.
Al Therwani S; Mose FH; Jensen JM; Bech JN; Pedersen EB
BMC Nephrol; 2014 Jun; 15():100. PubMed ID: 24965902
[TBL] [Abstract][Full Text] [Related]
3. Effect of tolvaptan on renal handling of water and sodium, GFR and central hemodynamics in autosomal dominant polycystic kidney disease during inhibition of the nitric oxide system: a randomized, placebo-controlled, double blind, crossover study.
Al Therwani S; Malmberg MES; Rosenbaek JB; Bech JN; Pedersen EB
BMC Nephrol; 2017 Aug; 18(1):268. PubMed ID: 28810844
[TBL] [Abstract][Full Text] [Related]
4. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension.
Mose FH; Jensen JM; Therwani S; Mortensen J; Hansen AB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 2015 Sep; 80(3):425-35. PubMed ID: 25778445
[TBL] [Abstract][Full Text] [Related]
5. Effect of volume expansion with hypertonic- and isotonic saline and isotonic glucose on sodium and water transport in the principal cells in the kidney.
Jensen JM; Mose FH; Bech JN; Nielsen S; Pedersen EB
BMC Nephrol; 2013 Sep; 14():202. PubMed ID: 24067081
[TBL] [Abstract][Full Text] [Related]
6. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes.
Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
Scand J Clin Lab Invest; 2014 Jan; 74(1):8-19. PubMed ID: 24256611
[TBL] [Abstract][Full Text] [Related]
7. Effect of sodium nitrite on renal function and sodium and water excretion and brachial and central blood pressure in healthy subjects: a dose-response study.
Rosenbaek JB; Al Therwani S; Jensen JM; Mose FH; Wandall-Frostholm C; Pedersen EB; Bech JN
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F378-F387. PubMed ID: 28490529
[TBL] [Abstract][Full Text] [Related]
8. Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease.
Mose FH; Larsen T; Jensen JM; Hansen AB; Bech JN; Pedersen EB
Br J Clin Pharmacol; 2014 Oct; 78(4):789-99. PubMed ID: 24697877
[TBL] [Abstract][Full Text] [Related]
9. Effect of amiloride and spironolactone on renal tubular function and central blood pressure in patients with arterial hypertension during baseline conditions and after furosemide: a double-blinded, randomized, placebo-controlled crossover trial.
Matthesen SK; Larsen T; Vase H; Lauridsen TG; Jensen JM; Pedersen EB
Clin Exp Hypertens; 2013; 35(5):313-24. PubMed ID: 22966789
[TBL] [Abstract][Full Text] [Related]
10. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
Bech JN; Nielsen CB; Pedersen EB
Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
[TBL] [Abstract][Full Text] [Related]
11. Effects of sodium nitrite on renal function and blood pressure in hypertensive vs. healthy study participants: a randomized, placebo-controlled, crossover study.
Rosenbæk JB; Hornstrup BG; Jørgensen AN; Mortensen J; Pedersen EB; Bech JN
J Hypertens; 2018 Mar; 36(3):666-679. PubMed ID: 29065098
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium nitrite infusion on renal function, brachial and central blood pressure during enzyme inhibition by allopurinol, enalapril or acetazolamide in healthy subjects: a randomized, double-blinded, placebo-controlled, crossover study.
Rosenbaek JB; Pedersen EB; Bech JN
BMC Nephrol; 2018 Sep; 19(1):244. PubMed ID: 30241504
[TBL] [Abstract][Full Text] [Related]
13. Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
Costello-Boerrigter LC; Smith WB; Boerrigter G; Ouyang J; Zimmer CA; Orlandi C; Burnett JC
Am J Physiol Renal Physiol; 2006 Feb; 290(2):F273-8. PubMed ID: 16189291
[TBL] [Abstract][Full Text] [Related]
14. Direct effect of methylprednisolone on renal sodium and water transport via the principal cells in the kidney.
Lauridsen TG; Vase H; Bech JN; Nielsen S; Pedersen EB
Eur J Endocrinol; 2010 May; 162(5):961-9. PubMed ID: 20203161
[TBL] [Abstract][Full Text] [Related]
15. Urinary excretion of aquaporin-2 after furosemide and felodipine in healthy humans.
Starklint J; Bech JN; Pedersen EB
Scand J Clin Lab Invest; 2005; 65(3):249-61. PubMed ID: 16095054
[TBL] [Abstract][Full Text] [Related]
16. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
Larsen T; Mose FH; Bech JN; Pedersen EB
Clin Exp Hypertens; 2012; 34(8):567-74. PubMed ID: 22559218
[TBL] [Abstract][Full Text] [Related]
17. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans.
Bech JN; Nielsen CB; Ivarsen P; Jensen KT; Pedersen EB
Am J Physiol; 1998 May; 274(5):F914-23. PubMed ID: 9612329
[TBL] [Abstract][Full Text] [Related]
18. Abnormal urinary excretion of NKCC2 and AQP2 in response to hypertonic saline in chronic kidney disease: an intervention study in patients with chronic kidney disease and healthy controls.
Jensen JM; Mose FH; Kulik AE; Bech JN; Fenton RA; Pedersen EB
BMC Nephrol; 2014 Jun; 15():101. PubMed ID: 24970686
[TBL] [Abstract][Full Text] [Related]
19. Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.
Vase H; Lauridsen TG; Bech JN; Pedersen EB
Scand J Clin Lab Invest; 2009; 69(1):45-51. PubMed ID: 18728933
[TBL] [Abstract][Full Text] [Related]
20. Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels.
Lauridsen TG; Vase H; Starklint J; Graffe CC; Bech JN; Nielsen S; Pedersen EB
BMC Nephrol; 2010 Oct; 11():28. PubMed ID: 21029429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
